91 related articles for article (PubMed ID: 8681404)
1. Structure-activity relationships of non-peptide vasopressin V1a antagonists: 1-(1-multi-substituted benzoyl 4-piperidyl)-3,4-dihydro-2(1H)-quinolinones.
Kondo K; Ogawa H; Nakaya K; Tominaga M; Yabuuchi Y
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):725-33. PubMed ID: 8681404
[TBL] [Abstract][Full Text] [Related]
2. Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihdyro-2(1H)-quinolinone.
Ogawa H; Yamamura Y; Miyamoto H; Kondo K; Yamashita H; Nakaya K; Chihara T; Mori T; Tominaga M; Yabuuchi Y
J Med Chem; 1993 Jul; 36(14):2011-7. PubMed ID: 8393113
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[5-(substituted methylidene)-2,3,4,5-tetrahydro-1H-1-ben zoazepine-1-carbonyl]benzanilide and 4'-[5-(substituted methyl)-2,3-dihydro-1H-1-benzoazepine-1- carbonyl]benzanilide derivatives.
Matsuhisa A; Kikuchi K; Sakamoto K; Yatsu T; Tanaka A
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):329-39. PubMed ID: 10212383
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzanil ide derivatives.
Matsuhisa A; Tanaka A; Kikuchi K; Shimada Y; Yatsu T; Yanagisawa I
Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1870-4. PubMed ID: 9396163
[TBL] [Abstract][Full Text] [Related]
5. Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium.
Atke A; Vilhardt H; Hauzerova L; Barth T; Andersen LF
Eur J Pharmacol; 1995 Jul; 281(1):63-8. PubMed ID: 8566118
[TBL] [Abstract][Full Text] [Related]
6. [Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
Bax WA; Van der Graaf PH; Stam WB; Bos E; Nisato D; Saxena PR
Eur J Pharmacol; 1995 Oct; 285(2):199-202. PubMed ID: 8566139
[TBL] [Abstract][Full Text] [Related]
7. Key amino acids of vasopressin V1a receptor responsible for the species difference in the affinity of OPC-21268.
Shinoura H; Take H; Itoh S; Hirasawa A; Inoue K; Ohno Y; Hashimoto K; Tsujimoto G
FEBS Lett; 2000 Jan; 466(2-3):255-8. PubMed ID: 10682838
[TBL] [Abstract][Full Text] [Related]
8. A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors.
Lemaire W; O'Brien JA; Burno M; Chaudhary AG; Dean DC; Williams PD; Freidinger RM; Pettibone DJ; Williams DL
Eur J Pharmacol; 2002 Aug; 450(1):19-28. PubMed ID: 12176104
[TBL] [Abstract][Full Text] [Related]
9. Highly potent and orally active non-peptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-y l)carbonyl]-2-phenylbenzanilide derivatives.
Shimada Y; Taniguchi N; Matsuhisa A; Sakamoto K; Yatsu T; Tanaka A
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1644-51. PubMed ID: 11086891
[TBL] [Abstract][Full Text] [Related]
10. Preparation of non-peptide, highly potent and selective antagonists of arginine vasopressin V1A receptor by introduction of alkoxy groups.
Shimada Y; Taniguchi N; Matsuhisa A; Yatsu T; Tahara A; Tanaka A
Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1075-80. PubMed ID: 12951451
[TBL] [Abstract][Full Text] [Related]
11. Organic osmolytes in rat renal inner medulla are modulated by vasopressin V1 and/or V2 antagonists.
Nakanishi T; Yamauchi A; Nakahama H; Yamamura Y; Yamada Y; Orita Y; Fujiwara Y; Uyeda N; Takamitsu Y; Sugita M
Am J Physiol; 1994 Jul; 267(1 Pt 2):F146-52. PubMed ID: 8048555
[TBL] [Abstract][Full Text] [Related]
12. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.
Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z
J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists.
Jiang J; DeVita RJ; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP
Bioorg Med Chem Lett; 2004 Apr; 14(7):1795-8. PubMed ID: 15026074
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de derivatives and 4'-(5,6-dihydro-4H-thiazolo[5,4-d][1]benzoazepine-6-carbonyl)benzanilid e derivatives.
Matsuhisa A; Taniguchi N; Koshio H; Yatsu T; Tanaka A
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):21-31. PubMed ID: 10705470
[TBL] [Abstract][Full Text] [Related]
15. Novel selective hindlimb vasodilators: synthesis and biological activity of 1-acyl-4-aminopiperidine derivatives.
Teramoto S; Tanaka M; Shimizu H; Fujioka T; Tabusa F; Imaizumi T; Yoshida K; Fujiki H; Mori T; Sumida T; Tominaga M
J Med Chem; 2003 Jul; 46(14):3033-44. PubMed ID: 12825942
[TBL] [Abstract][Full Text] [Related]
16. p38 Inhibitors: piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones.
Hunt JA; Kallashi F; Ruzek RD; Sinclair PJ; Ita I; McCormick SX; Pivnichny JV; Hop CE; Kumar S; Wang Z; O'Keefe SJ; O'Neill EA; Porter G; Thompson JE; Woods A; Zaller DM; Doherty JB
Bioorg Med Chem Lett; 2003 Feb; 13(3):467-70. PubMed ID: 12565952
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
Meiring L; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Calò G; Rizzi A; Traina L; Regoli D
Life Sci; 1997; 60(4-5):PL63-8. PubMed ID: 9010490
[TBL] [Abstract][Full Text] [Related]
19. Potent antagonistic action of OPC-31260, a vasopressin V2 receptor antagonist, on [Arg8]vasopressin-induced vasoconstriction in isolated simian femoral arteries.
Chiba S; Tsukada M
Eur J Pharmacol; 1992 Oct; 221(2-3):393-5. PubMed ID: 1330628
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl) benzanilide derivatives.
Matsuhisa A; Koshio H; Sakamoto K; Taniguchi N; Yatsu T; Tanaka A
Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1566-79. PubMed ID: 9810694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
